EP0454373B1 - Fibres de gomme gellan - Google Patents
Fibres de gomme gellan Download PDFInfo
- Publication number
- EP0454373B1 EP0454373B1 EP19910303521 EP91303521A EP0454373B1 EP 0454373 B1 EP0454373 B1 EP 0454373B1 EP 19910303521 EP19910303521 EP 19910303521 EP 91303521 A EP91303521 A EP 91303521A EP 0454373 B1 EP0454373 B1 EP 0454373B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- gum
- fibers
- gellan gum
- gellan
- alginate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F9/00—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments
Definitions
- GB-A-653,341 is an example of an early disclosure of the use of calcium alginate materials in surgical dressings. The earliest such materials were calcium alginate fibers, but they suffered from the disadvantage of being quite insoluble in water or wound exudate matter. Later a portion of the calcium ions in calcium alginate was exchanged with other cations, whose alginate salts are soluble. GB-A-653,341 therefore proposed that some of the calcium ions be replaced with sodium ions, to form a mixed salt alginate.
- alginate fibers have been proposed which involve shaping the fibers as by weaving or knitting into sheets or pads. These materials are useful because they absorb water and swell but retain their shape and structural integrity.
- GB-A-1 207 352 describes a water absorbent product of absorbent fibers prepared from one of several fiber forming materials, including guar gum.
- the guar gum fibers are formed by adding guar to an organic liquid, e.g. isopropyl alcohol, and adding the resulting slurry to excess water to precipitate a hydrate of the guar. The hydrate is then extruded into a coagulating bath to form the fibers.
- gellan gum fibers may be produced by extrusion of a gum solution into a gelling bath.
- the process advantageously, does not require esterification and subsequent hydrolysis.
- the process also produces hybrid fibers comprising gellan and one or more additional gums.
- gellan gum is meant the extracellularly produced gum made by the heteropolysaccharide-producing bacterium Pseudomonas elodea , ATCC 31461, by the whole culture fermentation under a variety of conditions of a medium comprising: a fermentable carbohydrate, a nitrogen source, and other appropriate nutrients. Included is the native, deacylated, partially deacylated, and clarified forms therefore. Gellan gum is also known as S-60.
- deacylated gellan gum described in U.S-A-4,326,052.
- gellan gum solutions containing 2-6% gum are extruded through fine orifices into coagulating baths containing various cations to produce filamentous fibers which can be used in wound dressings, catamenial devices, etc.
- Gellan gum may be used by itself or in combination with other polysaccharides such as alginates, xanthan gum, and locust bean gum. Solutions may be extruded cold (room temperature-50°C) or hot (50°-80°C); if hot, the addition of another gum is usually necessary. Gellan gum is especially useful for producing fibers containing magnesium for controlled release of that cation.
- the fibers may also contain known wound healing agents.
- the bath of gelling salts is an aqueous solution of 0.5-5% of a soluble salt, the cation of which may be mono-, di-, or tri-valent and selected from those of Groups I, II, and III of the Perodic Table, especially Na+, K+, Ca++, Mg++, and Al+++. Ca++ and Mg++ are especially preferred.
- the anion may be chloride sulfate, lactate, phosphate, carbonate, gluconate, or tartrate. Residence time is the bath is 5 seconds - 5 minutes.
- a second polysaccharide When a second polysaccharide is used it is one which exhibits a high viscosity when hot; in particular, algin, xanthan gum, and locust bean gum or combinations of these.
- the second gum can replace up to 33 1/3% of the gellan gum; i.e., up to 2% of a 6% gum solution may be comprised of one or more of a second polysaccharide.
- the ratio of gellan gum to said second gum is at least 2:1.
- algin is meant the soluble derivatives of alginic acid, which may be chemically extracted from all species of Phaeophyceae , brown algae.
- the term is intended to include the soluble salts of alginic acid (e.g., sodium, potassium, or ammonium alginate) and the salts of its ethers (e.g., propylene glycol alginate).
- xanthan gum is meant the biosynthetic polysaccharide produced by the organism Xanthomonas campestris by the whole culture fermentation of a medium comprising a fermentable carbohydrate, a nitrogen source and appropriate other nutrients.
- Xanthan gum preparation is described in numerous publications and patents, e.g., U.S. Patents 3,671,398; 3,594,280; 3,591,578; 3,481,889; 3,433,708; 3,427,226; 3,391,061; 3,391,060; 3,271,267; 3,251,749; and 3,020,206.
- Locust bean gum is an extract of the locust bean or carob, Ceratonia siligua . It is commercially available and used as a stabilizer in foods such as ice cream, sausages, and cheese.
- Gellan gum is normally gelled by heating an aqueous solution to dissolve the gum then simply cooling to produce a gel, provided cations are present. It is also known that solutions may be prepared cold in distilled or deionized water by the addition of a small amount of sequestrant.
- the sequestrants which can be used in this invention include trisodium orthophosphate (TSP), ethylenediaminetetraacetic acid (EDTA), sodium citrate, tetrasodium pyrophosphate (TSPP), sodium hexametaphosphate (Calgon) and the like.
- Gellan gum fibers can therefore be prepared by forcing a solution of 2.0% deacylated, clarified gellan gum containing 0.25% sodium citrate in deionized water through a nozzle having a diameter of eleven thousandth of an inch into a 2% calcium chloride bath where fiber formation immediately occurs.
- Gellan gum is particularly useful for forming fibers containing magnesium ions as it also gels in the presence of magnesium salts.
- the 2% gellan gum solution above was also forced into a bath containing 2% magnesium sulfate wherein fiber formation also immediately occurred.
- Fibers containing a source of magnesium are valuable additives to catamenial devices such as tampons where magnesium ions are said to prevent toxic shock syndrome.
- Magnesium alginate is soluble in water; therefore it cannot be formed by useful methods but must be formed by ion exchange from insoluble calcium alginate fibers already produced by the usual methods.
- a small amount can be formed simultaneously with gellan gum fibers however, by incorporating sodium alginate into gellan gum solutions before extrusion into the gelling bath.
- Fiber formation from hot solutions is more complicated.
- Gellan gum solutions have high viscosity when cold but low viscosity when heated, which makes it possible to prepare more concentrated solutions which gel more rapidly with higher gel strength. Fiber production by extrusion from hot gum solutions into a bath were not successful, however, because the low viscosity solution dispersed into flocs without forming a continuous fiber. It has been found that the addition of another polysaccharide which produces more viscosity at temperatures of 50-80°C make fiber formation possible.
- the high viscosity thickeners xanthan gum and locust bean gum or a combination of the two also produced fibers when combined with the gellan gum at levels of 0.5-1.0%.
- the fibers of this invention can be used in various forms. If a non-woven fabric is to be prepared, and this is the fabric of choice, a cotton card may be used to form a web, which may then be cross-lapped and then needle punched in conventional equipment.
- the fibers may be carded and then spun into a yarn, which can be woven in a conventional loom. Alternatively, the fibers may be collected in a spinning box, according to the method of Tallis (GB-A-568,177) and woven. If a knitted fabric is to be prepared, the fibers can be prepared as a continuous filament yarn (again according to GB-A-568,177) which is then knitted on a conventional knitting machine.
- the fiber end product (e.g., a pad) may include one or more antimicrobial (for example, antibacterial or antifungal) agents and/or one or more local anesthetics (for example, procaine) and additionally or alternatively one or more pharmaceutical agents.
- antimicrobial for example, antibacterial or antifungal
- local anesthetics for example, procaine
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Materials For Medical Uses (AREA)
- Artificial Filaments (AREA)
Claims (4)
- Fibre comprenant de la gomme gellane et une ou plusieurs d'une deuxième gomme qui est la gomme algine, xanthane ou de graine de caroube, dans laquelle le rapport de gomme gellane à ladite deuxième gomme est d'au moins de 2:1.
- Procédé de production de fibres de gomme gellane qui consiste à extruder une solution de gomme gellane de 2 à 6% dans un bain de coagulation comprenant 0,5 à 5,0% de sels gélifiants.
- Procédé selon la revendication 2, dans lequel les sels gélifiants sont de calcium ou de magnésium.
- Procédé selon la revendication 2, dans lequel la solution de gomme comprend une ou plusieurs d'une deuxième gomme qui est la gomme algine, xanthane ou de graine de caroube et dans lequel le rapport de gamme gellane à ladite deuxième gomme est d'au moins 2:1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51341290A | 1990-04-23 | 1990-04-23 | |
US513412 | 1990-04-23 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0454373A2 EP0454373A2 (fr) | 1991-10-30 |
EP0454373A3 EP0454373A3 (en) | 1993-01-20 |
EP0454373B1 true EP0454373B1 (fr) | 1995-08-23 |
Family
ID=24043154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19910303521 Expired - Lifetime EP0454373B1 (fr) | 1990-04-23 | 1991-04-19 | Fibres de gomme gellan |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0454373B1 (fr) |
JP (1) | JP2557572B2 (fr) |
CA (1) | CA2040959A1 (fr) |
DE (1) | DE69112260T2 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6387978B2 (en) | 1996-07-11 | 2002-05-14 | Boston Scientific Corporation | Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties |
USRE38158E1 (en) | 1994-07-27 | 2003-06-24 | Minnesota Mining And Manufacturing Company | Adhesive sealant composition |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5531716A (en) * | 1993-09-29 | 1996-07-02 | Hercules Incorporated | Medical devices subject to triggered disintegration |
AU4526296A (en) * | 1994-12-27 | 1996-07-19 | Monsanto Company | Gelled, alcohol-free carbonated beverage |
GB2310668B (en) * | 1996-02-28 | 2000-04-19 | Johnson & Johnson Medical | Solid polysaccharide materials for use as wound dressings |
US6368356B1 (en) | 1996-07-11 | 2002-04-09 | Scimed Life Systems, Inc. | Medical devices comprising hydrogel polymers having improved mechanical properties |
AU3868297A (en) * | 1996-08-27 | 1998-03-19 | San-Ei Gen F.F.I., Inc. | Novel use of native gellan gum |
US6453608B1 (en) * | 1997-10-31 | 2002-09-24 | Monsanto Company | Gellan gum seed coating |
US6913765B2 (en) | 2001-03-21 | 2005-07-05 | Scimed Life Systems, Inc. | Controlling resorption of bioresorbable medical implant material |
US8685943B2 (en) | 2003-03-12 | 2014-04-01 | Hill's Pet Nutrition, Inc. | Methods for reducing diarrhea in a companion animal |
EP1666075A1 (fr) | 2004-10-04 | 2006-06-07 | Switch Biotech Aktiengesellschaft | Pansements pour la libération d'inhibiteurs de protéase |
GB201500430D0 (en) | 2015-01-12 | 2015-02-25 | Univ Birmingham | Dressing |
WO2018078562A1 (fr) * | 2016-10-26 | 2018-05-03 | Association For The Advancement Of Tissue Engineering And Cell Based Technologies & Therapies (A4Tec) | Fibres à segments, leur préparation et leurs applications |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1207352A (en) * | 1967-10-16 | 1970-09-30 | David Torr | Disposable absorbent products |
JPS63267361A (ja) * | 1987-04-24 | 1988-11-04 | San Ei Chem Ind Ltd | 賦香等性ゲル状物 |
-
1991
- 1991-04-19 EP EP19910303521 patent/EP0454373B1/fr not_active Expired - Lifetime
- 1991-04-19 DE DE1991612260 patent/DE69112260T2/de not_active Expired - Fee Related
- 1991-04-22 CA CA 2040959 patent/CA2040959A1/fr not_active Abandoned
- 1991-04-23 JP JP3091910A patent/JP2557572B2/ja not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE38158E1 (en) | 1994-07-27 | 2003-06-24 | Minnesota Mining And Manufacturing Company | Adhesive sealant composition |
US6387978B2 (en) | 1996-07-11 | 2002-05-14 | Boston Scientific Corporation | Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties |
Also Published As
Publication number | Publication date |
---|---|
DE69112260T2 (de) | 1996-04-11 |
CA2040959A1 (fr) | 1991-10-24 |
JPH04222223A (ja) | 1992-08-12 |
JP2557572B2 (ja) | 1996-11-27 |
EP0454373A2 (fr) | 1991-10-30 |
DE69112260D1 (de) | 1995-09-28 |
EP0454373A3 (en) | 1993-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5230853A (en) | Process for making polysaccharide fibers | |
EP0454373B1 (fr) | Fibres de gomme gellan | |
US6080420A (en) | Fibres of cospun alginates | |
Blaine | Experimental observations on absorbable alginate products in surgery: gel, film, gauze and foam | |
DE69711540T3 (de) | Lösungsmittel-getrocknete Polysaccharidschwämme | |
US6258995B1 (en) | Wound treatment composition | |
EP2764146B1 (fr) | Fibres polysaccharidiques pour pansements pour plaies | |
JP2015522720A (ja) | 多糖類繊維の調製方法,多糖類繊維を含有する創傷被覆材,創傷被覆材の製造方法,及び多糖類繊維の調製装置 | |
CN100457989C (zh) | 高强度海藻酸/明胶共混纤维的制备方法 | |
CN1940153A (zh) | 壳聚糖接枝海藻纤维及其制备方法与用途 | |
WO2014201484A1 (fr) | Fibres de polysaccharide à fort pouvoir absorbant et leur utilisation | |
US4205025A (en) | Synthetic polymeric fibrids, fibrid products and process for their production | |
JPS60173161A (ja) | pH−値を調節する材料及びその製造方法 | |
EP0880547B1 (fr) | Fibres de pectine | |
JP2016502612A (ja) | N‐アセチル‐d‐グルコサミン基の6位が選択的に酸化されたヒアルロナンをベースとするエンドレスファイバー,その調製及び使用,該エンドレスファイバーから成る糸,ステープル,織り糸,生地,並びにその修飾方法 | |
US3591578A (en) | Process for treating polysaccharides produced by fermentation | |
CN113529419A (zh) | 负载纳米氧化锌的细菌纤维素微纤-海藻酸纤维复合材料 | |
KR20110116069A (ko) | 셀룰로오스 성형체의 제조 방법 | |
EP0860522A1 (fr) | Procédé de fabrication d'articles moulés à base de mélanges de polysaccharides | |
Niekraszewicz et al. | The structure of alginate, chitin and chitosan fibres | |
US2030566A (en) | Production of films | |
CN100547130C (zh) | 壳聚糖/淀粉共混载药纤维及其制备方法和用途 | |
CN1156618C (zh) | 魔竽生物全降解纤维及其制备方法 | |
JP2660255B2 (ja) | アルギン酸系繊維、その製造方法及びその製品 | |
CN114642772A (zh) | 一种黄蓍胶/壳聚糖/杂化纳米磷灰石三元复合多孔材料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): CH DE FR GB IT LI NL |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): CH DE FR GB IT LI NL |
|
17P | Request for examination filed |
Effective date: 19930607 |
|
17Q | First examination report despatched |
Effective date: 19930826 |
|
ITF | It: translation for a ep patent filed |
Owner name: SOCIETA' ITALIANA BREVETTI S.P.A. |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): CH DE FR GB IT LI NL |
|
REF | Corresponds to: |
Ref document number: 69112260 Country of ref document: DE Date of ref document: 19950928 |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: MONSANTO COMPANY |
|
ET | Fr: translation filed | ||
ITPR | It: changes in ownership of a european patent |
Owner name: CESSIONE EPO;MONSANTO COMPANY |
|
NLT2 | Nl: modifications (of names), taken from the european patent patent bulletin |
Owner name: MONSANTO COMPANY |
|
NLXE | Nl: other communications concerning ep-patents (part 3 heading xe) |
Free format text: PAT.BUL.01/96 PAGE 65:CORR.:MONSANTO COMPANY |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PUE Owner name: MERCK & CO., INC. TRANSFER- MONSANTO COMPANY |
|
26N | No opposition filed | ||
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20020329 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20020401 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20020403 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20020416 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20020418 Year of fee payment: 12 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030419 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030430 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20031101 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20031101 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20031101 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20030419 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20031231 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20050419 |